VIDEX (Bristol-Myers Squibb Company)
Welcome to the PulseAid listing for the VIDEX drug offered from Bristol-Myers Squibb Company. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Bristol-Myers Squibb Company |
NON-PROPRIETARY NAME: | didanosine |
SUBSTANCE NAME: | DIDANOSINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1991-10-09 |
END MARKETING DATE: | 0000-00-00 |
VIDEX HUMAN PRESCRIPTION DRUG Details:
Item Description | VIDEX from Bristol-Myers Squibb Company |
LABELER NAME: | Bristol-Myers Squibb Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 1991-10-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0087-6632_a615c855-1dca-4aba-88a9-5a7be7e5ad5a |
PRODUCT NDC: | 0087-6632 |
APPLICATION NUMBER: | NDA020156 |
Other DIDANOSINE Pharmaceutical Manufacturers / Labelers: